This idea that you have to ‘ opt in ’ sounds really, really, good, but when you start to think about benefits, when you start to think about the amount of paperwork people fill out when they join a company, nobody understands everything they are opting in to, so, that is n’t really a protection.

Johnson Johnson

Categorized in : U.S.

In addition to those fundamental legal defects, the State undenia... by Johnson Johnson

In addition to those fundamental legal defects, the State undeniably failed to prove its case.

Johnson Johnson

top-news

In sum, The State failed to prove that Janssen misleadingly promoted opioids, that any of Janssen's promotions caused any harm in Oklahoma( let alone a crisis of opioid abuse), or that its proposed remedy was a prudent and justified response to the present crisis.

Johnson Johnson

us-news

This case illustrates the absurd results that flow from such lega... by Johnson Johnson

This case illustrates the absurd results that flow from such legal distortions.

Johnson Johnson

us-news

A great business opportunity is out there right now for somebody right now to solve the problem of the decentralized medical records.

Johnson Johnson

us

The Company is testing blood serum from participants in completed and ongoing booster studies to look for neutralizing activity against the Omicron variant.

Johnson Johnson

The decision is based on data from ongoing stability assessment studies, which have demonstrated that Johnson Johnson Covid-19 vaccine is stable at 4.5 months when refrigerated at temperatures of 36-46 degrees Fahrenheit.

Johnson Johnson

The science tells us that vaccines are 95 % effective. So if you have a vaccine, quite honestly, what do you care if your neighbor has one or not ? I mean, what is it to you ? you got a vaccine, and science is telling you it's very, very effective. So why is this big push to make sure everybody gets a vaccine ?

Johnson Johnson

The safety and well-being of the people who use our products is our number one priority, we have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public.

Johnson Johnson

Although this is a small percentage of the overall vaccines that the county has received, we know it is not insignificant — this is a heart-wrenching situation for our hospital, our Phase 2 community members and our Unified Command partners.

Johnson Johnson

The pandemic shows no signs of slowing, and we, like everyone, are eager for more tools to help stop it. At the same time, it is premature to get into the specifics of the supply of our vaccine candidate, as we do not yet have Phase 3 data, nor have we filed for or been granted Emergency Use Authorization, we remain in active discussions with regulators, including on the approval and validation of our manufacturing processes.

Johnson Johnson

The Company anticipates announcing topline Phase 3 data for its single-dose Janssen COVID-19 vaccine candidate in late January 2021 ; however, as this trial is dependent on disease events, the timing is approximate.

Johnson Johnson

A study pause, in which recruitment or dosing is paused by the study sponsor, is a standard component of a clinical trial protocol, a regulatory hold of a clinical trial is a requirement by a regulatory health authority, such as the U.S. Food and Drug Administration. As outlined in our transparency commitments, we proactively disclose any regulatory hold of a pivotal clinical trial.

Johnson Johnson